Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine

Added 557 days ago (05.11.2020)
Authors: Caroline M Kopruszinski; Peter Thornton; Joanne Arnold; Philip Newton; David Lowne; Edita Navratilova; Juliana Swiokla; David W Dodick; Claire Dobson; Ian Gurrell; Iain Patrick Chessell; Frank Porreca
Journal: Cephalalgia
Read article